Key result
A six-factor nomogram predicts coronary heart disease in snoring hypertensive patients with ~0.70 accuracy.
Why the study?
Blood glucose is a potent predictor of coronary heart disease that may mask other predictive factors, leading to clinical neglect of other risk factors.
Can a nomogram model incorporating apnea index and clinical factors predict coronary heart disease in snoring patients with hypertension and non-glucose metabolism disorders?
Cohort (n=2,105)
Can a nomogram model incorporating apnea index and clinical factors predict coronary heart disease in snoring patients with hypertension and non-glucose metabolism disorders?
A novel nomogram incorporating the apnea index alongside traditional risk factors provides moderate predictive accuracy for coronary heart disease in snoring patients with hypertension but without glucose metabolism disorders.
Answers are grounded in this paper and cite their sources.
May aid CHD risk stratification in snoring hypertensives; leaves open external validation before clinical adoption.
Background: Snoring, as a common disease, may lead to various cardiovascular diseases. scholars attach importance to the relationship between snoring or sleep breathing disorders and glucose metabolism disorders. Some predictive model for predicting sleep-disordered breathing in patients with diabetes has been developed. Studies have found that blood glucose is an inevitable predictor of the outcome of coronary heart disease. It may mask other predictive factors, leading to clinical neglect of the control of other risk factors. So we developed and validated a nomogram to predict the risk of coronary heart disease in hypertensive patients who snore, excluding those with glucose metabolism disorders. Methods: Records from 2105 snoring patients with hypertension and non-glucose metabolism disorders. A random grouping technique was utilized to split the data into validation and derivation datasets (split ratio = 0.7: 0.3). Least absolute shrinkage and selection operator regression was applied to select predictors and constructed a nomogram model based on multivariate Cox regression analysis. The discrimination and consistency of the nomogram were evaluated using the area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analysis (DCA) to assess its performance. We found age, male, waist-to-height ratio (WHtR), low and high-density lipoprotein cholesterol (LDL-C and HDL-C), and apnea index (AI) identified as predictors to generate this nomogram model. Results: The C-index at 84 months was 0.703 (95% confidence interval 0.653-0.754) in the derivation set and 0.645 (95% confidence interval 0.562-0.728) in the validation set. The nomogram demonstrated good performance in the calibration curve and DCA. Conclusions: So, our study proposed an effective nomogram model with potential application value for individualized prediction of coronary heart disease outcomes in snoring individuals with hypertension, excluding glucose metabolism disorders. And "AI" was proposed as a novel predictor.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2025) conducted a cohort in Snoring patients with hypertension and non-glucose metabolism disorders (n=2,105). Nomogram model was evaluated on Coronary heart disease (C-index, 95% CI 0.653-0.754). A nomogram model incorporating age, male sex, WHtR, LDL-C, HDL-C, and apnea index predicted coronary heart disease in snoring hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: